Asenapine Impurity 13 | CAS 1012884-46-6 - Request Quote
Asenapine Impurity 13
| SZ CAT No: | SZ-A071024 |
| CAS No | 1012884-46-6 |
| Mol.F. | C17H12ClNO2 |
| Mol.Wt. | 297.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Asenapine Impurity 13 is chemically 11-Chloro-2-methyl-2,3-dihydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrol-1-one. Asenapine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Asenapine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Asenapine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1012884-46-6
Purchase 1012884-46-6
Order 1012884-46-6
Enquire 1012884-46-6
price of 1012884-46-6
1012884-46-6 Supplier
1012884-46-6 Manufacturer
1012884-46-6 Exporter
buy high quality Asenapine Impurity 13
Purchase Asenapine Impurity 13
Asenapine Impurity 13 suppliers
Asenapine Impurity 13 manufacturers
Asenapine Impurity 13 price
Order Asenapine Impurity 13
Enquire Asenapine Impurity 13
Asenapine Impurity 13 cost
Asenapine Impurity 13 Supplier
Asenapine Impurity 13 Distributor
Asenapine Impurity 13 for Method Validation
Asenapine Reference Standard
Asenapine Impurity 13 for ANDA Filing
Asenapine Impurity 13 for Forced Degradation Studies
Asenapine Impurity 13 Identification Standards
Asenapine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


